Wearable injectors (WIs) are delivery systems that adhere to the body to administer larger volumes (more than 2 mL) of drug subcutaneously over an extended period.
This report contains market size and forecasts of Wearable Injector Devices in global, including the following market information:
Global Wearable Injector Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Wearable Injector Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Wearable Injector Devices companies in 2021 (%)
The global Wearable Injector Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Disposable Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wearable Injector Devices include SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AGInsulet Corporation, Enable Injections, Becton, West Pharmaceutical Services, Inc., Ypsomed, Amgen and Buhler Motor GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wearable Injector Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wearable Injector Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Wearable Injector Devices Market Segment Percentages, by Type, 2021 (%)
Disposable
Reusable
Global Wearable Injector Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Wearable Injector Devices Market Segment Percentages, by Application, 2021 (%)
Oncology
Diabetes
Cardiovascular Diseases
Autoimmune Disorder
Infectious Diseases
Others
Global Wearable Injector Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Wearable Injector Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wearable Injector Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Wearable Injector Devices revenues share in global market, 2021 (%)
Key companies Wearable Injector Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Wearable Injector Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SteadyMed Therapeutics, Inc.
UNILIFE CORPORATION
Sensile Medical AGInsulet Corporation
Enable Injections
Becton
West Pharmaceutical Services, Inc.
Ypsomed
Amgen
Buhler Motor GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
CeQur SA.